FDCP
BMY icon

Foster Dykema Cabot & Partners’s Bristol-Myers Squibb BMY Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.7K Hold
1,348
– – ﹤0.01% 163
2026
Q1 		$81.8K Hold
1,348
– – 0.01% 163
2025
Q4 		$72.7K Sell
1,348
-549
-29% -$26.4K ﹤0.01% 176
2025
Q3 		$84.4K Buy
1,897
+679
+56% +$31.7K 0.01% 184
2025
Q2 		$56.5K Hold
1,218
– – ﹤0.01% 186
2025
Q1 		$74.3K Hold
1,218
– – 0.01% 172
2024
Q4 		$68.9K Hold
1,218
– – 0.01% 187
2024
Q3 		$63K Hold
1,218
– – 0.01% 199
2024
Q2 		$50.6K Hold
1,218
– – ﹤0.01% 176
2024
Q1 		$66.1K Hold
1,218
– – 0.01% 166
2023
Q4 		$62.5K Buy
+1,218
New +$63.9K 0.01% 144

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Foster Dykema Cabot & Partners's BMY Position: Q2 2026 in Review

Foster Dykema Cabot & Partners held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 1,348 shares worth $77.7K. The position accounts for ﹤0.01% of the portfolio, ranked #163.

Foster Dykema Cabot & Partners first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $84.4K in Q3 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Foster Dykema Cabot & Partners held 1,348 shares of Bristol-Myers Squibb worth $77.7K as of Q2 2026.
  • Foster Dykema Cabot & Partners left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #163 holding.
  • Foster Dykema Cabot & Partners first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • Foster Dykema Cabot & Partners's Bristol-Myers Squibb position peaked at $84.4K in Q3 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.